Indraprastha Medical Corporation logo

Indraprastha Medical Corporation financials: balance sheet, profit and loss, cash flow

NSE: INDRAMEDCOBSE: 532150Healthcare ServicesSmall Cap

Indraprastha Medical Corporation Limited · Face value ₹10 · Listed Apr 1997 on NSE, May 1997 on BSE
Last close ₹305.65down ₹12.65 (3.97%)BSE ₹305.15

Share price at the NSE close on 30 Oct 2026. Previous close ₹318.30.

30 Oct: open ₹312.00, high ₹313.45, low ₹302.00

52-week range of traded prices to 30 Oct 2026
₹293.65Low, 23 Oct 2026₹640.85High, 6 Nov 2025
Market cap
₹2,802 Cr899th largest listed
P/E
14.58
P/B
3.44
Dividend yield
1.31%
ROE
26.1%
ROCE
28.6%
Debt to equity
0.00
Volume, NSE
1,12,67348.3% delivered

Indraprastha Medical Corporation's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the half year to Sep 2026 after them. It had no borrowings at 30 Sep 2026.

10 years at a glance

₹ crore, years to March.Indraprastha Medical Corporation annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
76626Mar 1774821Mar 187882815Mar 19831444.0Mar 206132.30Mar 21888590Mar 221,099860Mar 231,2451240Mar 241,3561610Mar 251,4831840Mar 26
Peak revenue ₹1,483 Cr, year to Mar 2026; lowest ₹613 Cr, year to Mar 2021

Operating and net margin, per cent

  • Operating margin
  • Net margin
18.0%0.4%10.1%9.6%10.2%10.4%6.6%12.9%13.7%15.5%18.0%18.0%3.4%2.8%3.6%5.3%0.4%6.6%7.8%10.0%11.9%12.4%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 5.2% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1,483
  2. Materials and goods−256
  3. Employee costs−288
  4. Other expenses−672
  5. Operating profit267
  6. Depreciation−44
  7. Other income+29
  8. One-off items0.0
  9. Finance costs−6.0
  10. Profit before tax246
  11. Tax−62
  12. Net profit184

What the company owns

  • Plant, investments and other assets₹608 Cr
  • Cash and bank₹263 Cr
  • Receivables₹112 Cr
  • Inventory₹8 Cr

What pays for it: net worth and liabilities

  • Net worth₹740 Cr
  • Owed to suppliers₹128 Cr
  • Other liabilities₹123 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest four quarters added.Indraprastha Medical Corporation quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 9 MayMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 16 MayMar 2026Filed 12 MaySep 2026Twelve monthsFiled 29 Oct
Revenue from operations7667487888316138881,0991,2451,3561,4831,555
6886767077445737749481,0511,1121,2161,276
Materials and goods bought150140145152114174194217230256266
Employee costs––200214198215247262277288301
Other expenses––362379262385508573605672710
Operating profit before depreciation7872818640114151193244267280
Operating margin10.1%9.6%10.2%10.4%6.6%12.9%13.7%15.5%18.0%18.0%18.0%
Materials, % of revenue––18.4%18.2%18.6%19.6%17.6%17.4%17.0%17.3%17.1%
Employee costs, % of revenue––25.4%25.8%32.2%24.2%22.5%21.0%20.4%19.4%19.3%
Other expenses, % of revenue––46.0%45.6%42.6%43.4%46.2%46.0%44.6%45.3%45.6%
Depreciation and amortisation3131303333353940444447
Operating profit after depreciation47415153779111153200223233
Other income2201131017232931
Finance costs89763344666
One-off items––000000000
Profit before tax41344548479117166216246258
15131652203142556266
Net profit2621284425986124161184192
Other comprehensive income––0−23−6−92−111
Total comprehensive income––284255377126160185193
Net margin3.4%2.8%3.6%5.3%0.4%6.6%7.8%10.0%11.9%12.4%12.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations315406436458523607678713758
294344367392455528587629681
Materials and goods bought–––––142151145152
Operating profit before depreciation216270666879918576
Operating margin6.6%15.2%16.0%14.4%13.0%12.9%13.4%11.9%10.1%
Depreciation and amortisation161919212226282827
Operating profit after depreciation54350454653635750
Other income28––4–1112
Finance costs6644691087
Profit before tax263747454045545044
Tax101315151317191716
Net profit162431312729353228
Net margin5.1%5.9%7.1%6.7%5.2%4.7%5.2%4.6%3.7%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Filed 9 MayMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 16 MayMar 2026Filed 12 MaySep 2026Half yearFiled 29 Oct
244268273325379478597740814
Share capital929292929292929292
Reserves152176181234288386505649723
1540000000
12414011694130165179170223
544243434680768181
Total assets4224494324625557238529911,118
287308291304332415420575605
136141141157223308431417513
Net debt−7−20−28−68−129−224−322−263−345
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 16 MayMar 2026Filed 12 MaySep 2026Half year
2871144200157167109
3791154247218234137
−1−26755−24−30−18
Receivables103−2314−19−32−25
Inventories3−1211−10
Payables−14−282941−537
Tax paid−9−20−10−47−61−67−28
Interest paid0000000
Capital spending21294569366033
Free cash flow74210013112010877
−20−51−108−158−111−178−101
−3−3−26−32−46−46−6
Dividends paid00232841413
Shares bought back0000000
Shares issued0000000
Net change in cash5171190−572
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Indraprastha Medical Corporation dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 9 MayMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 16 MayMar 2026Filed 12 May
Earnings per share₹2.86₹2.30₹3.10₹4.76₹0.25₹6.39₹9.40₹13.52₹17.56₹20.03
Diluted earnings per share₹2.86₹2.30₹3.10₹4.76₹0.25₹6.39₹9.40₹13.52₹17.56₹20.03
Dividend per share₹1.80₹1.50₹1.60––₹2.50₹3.00₹4.50₹4.50₹4.00
Book value per share––₹26.62₹29.21₹29.75₹35.50₹41.39₹52.12₹65.09₹80.76
Dividend payout62.9%65.2%51.6%––39.1%31.9%33.3%25.6%20.0%
Shareholder yield––––0.0%0.0%3.2%1.8%1.2%1.2%
Market cap at the year end (₹ crore)4874453523114925357061,5713,5393,413
RatioMar 2017Mar 2018Mar 2019Filed 9 MayMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 16 MayMar 2026Filed 12 May
Revenue growth1.1%−2.3%5.3%5.4%−26.2%44.8%23.7%13.3%9.0%9.3%
Operating profit growth1.8%−7.3%12.2%6.9%−53.4%183.8%31.8%28.3%26.3%9.3%
Net profit growth−7.0%−19.6%34.6%53.5%−94.7%2,417.0%47.0%43.9%29.9%14.1%
Earnings per share growth–−19.6%34.8%53.5%−94.7%2,456.0%47.1%43.8%29.9%14.1%
––11.6%17.0%0.9%19.6%24.4%28.9%30.0%27.5%
–––5.4 pts−16.2 pts18.7 pts4.8 pts4.5 pts1.0 pts−2.5 pts
From the net margin–––5.3 pts−15.8 pts14.1 pts3.7 pts6.6 pts5.5 pts1.3 pts
From asset turnover–––0.4 pts−0.3 pts6.4 pts2.0 pts−3.1 pts−4.0 pts−2.1 pts
From borrowing–––−0.3 pts0.0 pts−1.8 pts−0.9 pts0.9 pts−0.5 pts−1.7 pts
Return on capital employed––19.7%19.7%2.5%24.4%29.4%32.1%33.5%30.2%
Cash conversion––––1,197.9%121.6%167.7%161.5%97.4%91.2%
Interest cover6.04.67.49.02.123.326.037.831.937.1
Debt to equity––0.060.010.000.000.000.000.000.00
Receivable days––3535401823172028
Inventory days––2129282116131111
Payable days––229250294161185235194182
Cash conversion cycle, days––−173−186−226−122−146−205−163−144
Working capital days––−5−8−1−2−12−24−19−4
Asset turnover––1.871.911.391.992.161.951.721.61
Assets per rupee of net worth––1.731.701.631.491.441.491.471.38
Sales per rupee of plant––2.822.762.193.234.013.604.144.07
Capital spending to depreciation––––0.630.841.141.730.821.37
Plant being built, % of plant in use––0.4%0.0%1.2%0.0%0.9%0.1%9.9%0.8%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
19.9%
Cash from operations against operating profit
62.7%
Measure10 years5 years3 years
Revenue growth, yearly rate6.9%19.3%10.5%
Profit growth, yearly rate20.6%139.5%28.7%
Return on equity, average–26.1%28.8%
Return on capital employed, average–29.9%31.9%
Operating margin, average12.5%15.6%17.2%
Net margin, average6.4%9.7%11.4%
Asset turnover, average–1.891.76
Cash conversion cycle, days, average–−156−170
Interest cover, average18.531.235.6
Debt to equity, average–0.000.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations740524167
Cash from investing−606−447−178
Cash from financing−154−125−46
Capital spending23916560
Dividends paid13210941
Shares bought back000
Shares issued for cash000
Borrowings raised000
Borrowings repaid000

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––578754
Altman Z-scorePublished threshold 1.81––3.993.833.995.756.047.3211.9711.71
Beneish M-scorePublished threshold −1.78––––−2.50−1.99−2.32−3.08−2.14−1.53
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−1.238.609.7512.8714.6321.03
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––1.661.551.351.12
Receivables growth less revenue growthOur threshold 0 percentage points–––−1.5311.31−80.4733.71−27.7120.2239.35
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––40.51−2.68−38.25−26.86−23.07−13.281.22
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−0.281.92−0.24−1.640.000.690.43
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.280.000.070.001.260.03
Effective tax ratePublished threshold 17.16 per cent35.7037.9436.329.4845.7025.8626.4825.3725.5825.36
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––1.1918.07−2.82−2.61−1.84
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
26 May 2026ICRA LimitedFund-based-Term loan[ICRA]AAReview, Re-affirmStable92.50
26 May 2026ICRA LimitedNon-fund based-Others[ICRA]A1+Review, Re-affirm30
26 May 2026ICRA LimitedFund-based-Cash credit[ICRA]AAReview, Re-affirmStable40
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.